Insulin Pump Occlusions: For Patients Who Have Been Around the (Infusion) Block.
作者信息
Klonoff David C, Freckmann Guido, Heinemann Lutz
机构信息
1 Mills-Peninsula Medical Center, San Mateo, CA, USA.
2 Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.
出版信息
J Diabetes Sci Technol. 2017 May;11(3):451-454. doi: 10.1177/1932296817700545. Epub 2017 Mar 30.
Abstract
摘要
相似文献
1
Insulin Pump Occlusions: For Patients Who Have Been Around the (Infusion) Block.
J Diabetes Sci Technol. 2017 May;11(3):451-454. doi: 10.1177/1932296817700545. Epub 2017 Mar 30.
2
Identifying patients for insulin pump therapy.
Nurs Times. 2013;109(10):14, 16, 18.
3
Challenges in Delivering Smaller Doses of Insulin.
Diabetes Technol Ther. 2015 Sep;17(9):597-9. doi: 10.1089/dia.2015.0268.
4
Insulin pump treatment in children and adolescents with type 1 diabetes: experiences of the German working group for insulin pump treatment in pediatric patients.
Postgrad Med. 2010 May;122(3):98-105. doi: 10.3810/pgm.2010.05.2147.
5
6
Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
J Am Pharm Assoc (2003). 2009 Jan-Feb;49(1):e1-13; quiz e14-7. doi: 10.1331/JAphA.2009.08122.
7
[Influence of the treatment with continuous subcutaneous insulin infusion (CSII) in the improvement of the quality of life of patients with type 1 diabetes mellitus].
Enferm Clin. 2010 Jul-Aug;20(4):216-21. doi: 10.1016/j.enfcli.2010.05.002. Epub 2010 Jun 18.
8
Insulin-pump therapy for type 1 diabetes mellitus.
N Engl J Med. 2012 Jul 26;367(4):383; author reply 383-4. doi: 10.1056/NEJMc1206221.
9
Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
Diabetes Technol Ther. 2013 Apr;15(4):289-94. doi: 10.1089/dia.2012.0319. Epub 2013 Feb 21.
10
Personal Insulin Pump With Predictive Low Glucose Management Technology at High Altitude.
J Diabetes Sci Technol. 2017 Jan;11(1):176-177. doi: 10.1177/1932296816649973. Epub 2016 Jul 10.
引用本文的文献
1
Does the Type of Cannula Matter? A Case Report and Review of the Evidence Regarding Steel and Plastic Cannulae With Respect to a Continuous Subcutaneous Insulin Infusion.
Cureus. 2024 Nov 18;16(11):e73900. doi: 10.7759/cureus.73900. eCollection 2024 Nov.
2
Advancements in Insulin Pumps: A Comprehensive Exploration of Insulin Pump Systems, Technologies, and Future Directions.
Pharmaceutics. 2024 Jul 15;16(7):944. doi: 10.3390/pharmaceutics16070944.
3
Supervised and Unsupervised Approaches for the Real-Time Detection of Undesired Insulin Suspension Caused by Malfunctions.
J Diabetes Sci Technol. 2024 Apr 29:19322968241248402. doi: 10.1177/19322968241248402.
4
Development of a Real-time Force-based Algorithm for Infusion Failure Detection.
J Diabetes Sci Technol. 2024 Nov;18(6):1313-1323. doi: 10.1177/19322968241247530. Epub 2024 Apr 23.
5
Ketone-Based Alert System for Insulin Pump Failures.
J Diabetes Sci Technol. 2025 May;19(3):683-691. doi: 10.1177/19322968231209339. Epub 2023 Nov 9.
6
Insulin Pump Alarms During Adverse Events: A Qualitative Descriptive Study.
J Diabetes Sci Technol. 2025 May;19(3):739-748. doi: 10.1177/19322968231209999. Epub 2023 Oct 31.
7
Frequency and Detection of Insulin Infusion Site Failure in the Type 1 Diabetes Exchange Online Community.
Diabetes Technol Ther. 2023 Jun;25(6):426-430. doi: 10.1089/dia.2023.0005. Epub 2023 Mar 20.
8
Continuous Ketone Monitoring Consensus Report 2021.
J Diabetes Sci Technol. 2022 May;16(3):689-715. doi: 10.1177/19322968211042656. Epub 2021 Oct 4.
9
Advances in Insulin Pump Infusion Sets Symposium Report.
J Diabetes Sci Technol. 2021 May;15(3):705-709. doi: 10.1177/1932296821999080. Epub 2021 Mar 11.
10
Replacing Pumps with Light Controlled Insulin Delivery.
Curr Diab Rep. 2019 Nov 6;19(11):122. doi: 10.1007/s11892-019-1233-3.
本文引用的文献
1
Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes.
J Diabetes Sci Technol. 2016 Nov 1;10(6):1268-1276. doi: 10.1177/1932296816663962. Print 2016 Nov.
2
Improving Patient Experience With Insulin Infusion Sets: Practical Guidelines and Future Directions.
Diabetes Educ. 2016 Aug;42(4):470-84. doi: 10.1177/0145721716642526. Epub 2016 Apr 7.
3
Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies.
Diabetes Technol Ther. 2016 Mar;18(3):136-43. doi: 10.1089/dia.2015.0342. Epub 2015 Dec 24.
4
Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study.
J Diabetes Sci Technol. 2015 Sep 3;9(6):1292-8. doi: 10.1177/1932296815604438.
5
Accuracy of a new patch pump based on a microelectromechanical system (MEMS) compared to other commercially available insulin pumps: results of the first in vitro and in vivo studies.
J Diabetes Sci Technol. 2014 Nov;8(6):1133-41. doi: 10.1177/1932296814543946. Epub 2014 Jul 30.
6
Safety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose.
Diabetes Care. 2014;37(3):773-9. doi: 10.2337/dc13-1608. Epub 2013 Oct 29.
7
An online failure detection method of the glucose sensor-insulin pump system: improved overnight safety of type-1 diabetic subjects.
IEEE Trans Biomed Eng. 2013 Feb;60(2):406-16. doi: 10.1109/TBME.2012.2227256. Epub 2012 Nov 15.
8
Robust fault detection system for insulin pump therapy using continuous glucose monitoring.
J Diabetes Sci Technol. 2012 Sep 1;6(5):1131-41. doi: 10.1177/193229681200600518.
9
Significant time until catheter occlusion alerts in currently marketed insulin pumps at two basal rates.
Diabetes Technol Ther. 2012 May;14(5):447-8. doi: 10.1089/dia.2011.0259.
10
Insulin glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trial.
Diabetes Technol Ther. 2011 Jun;13(6):607-14. doi: 10.1089/dia.2010.0224. Epub 2011 Apr 2.
Zotero 插件